Inventor · disambiguated record
Denis-Claude Roy
Also filed as: ROY DENIS · ROY DENIS C · ROY DENIS CLAUDE
7 granted patents·2 pending applications·59 citations·filing 1994–2013
84Inventor score
Files withROY DENIS CLAUDE2TATARKIEWICZ KRYSTYNA2British Columbia Caner Agency Branch1HOPITAL MAISONNEUVE ROSEMONT1INST MEDECINE DE LA REPRODUCTI1
Top patents by PatentIndex Score
9 records- 0189US8263554B2Methods of using GLP-1 receptor agonists to treat pancreatitisTATARKIEWICZ KRYSTYNA·Filed 2011·Granted Sep 11, 2012·18 cites·18 claims
- 0287US8481490B2Method of reducing plasma amylase and/or plasma lipase in patients with pancreatitisTATARKIEWICZ KRYSTYNA·Filed 2012·Granted Jul 9, 2013·14 cites·4 claims
- 0370US8039436B2Mutated HOXB4 proteins with improved stability, and methods of use thereofBritish Columbia Caner Agency Branch·Filed 2008·Granted Oct 18, 2011·2 cites·21 claims
- 0462US8802082B2Rhodamine derivatives for photodynamic diagnosis and treatmentUniversité de Montreal·Filed 2013·Granted Aug 12, 2014·1 cites·1 claims
- 0561US8409564B2Rhodamine derivatives for photodynamic diagnosis and treatmentROY DENIS-CLAUDE·Filed 2004·Granted Apr 2, 2013·2 cites·2 claims
- 0649US2007098732A1Immunologic compounds for prevention, protection, prophylaxis or treatment of immunological disorders, infections and cancerHOPITAL MAISONNEUVE ROSEMONT·Filed 2004·Application pending·0 cites
- 0739US6376201B2Use of ligands specific to major histocompatibility complex-class I antigens for diagnosing endometriosisPROCREA BIOSCIENCES INC·Filed 1999·Granted Apr 23, 2002·10 cites·15 claims
- 0839US2012136338A1Immunologic compounds for prevention, protection, prophylaxis or treatment of immunological disorders, infections and cancerROY DENIS CLAUDE·Filed 2012·Application pending·0 cites
- 0938US5618680AUse of ligands specific to major histocompatibility complex-class I antigens for diagnosing endometriosisINST MEDECINE DE LA REPRODUCTI·Filed 1994·Granted Apr 8, 1997·12 cites·13 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →